The combined proteomic and transcriptome analysis of CSF IgG in NMO patients suggests that CNS AQP4-IgG is a product of both passive transit from circulating serum IgG and intrathecal plasmablasts and plasma cells (Figure 2). The gene discussed is AQP4; the disease is neuromyelitis optica.